| Literature DB >> 32927664 |
Kelsey A Heenan1, Andres E Carrillo1,2, Jacob L Fulton1, Edward J Ryan1, Jason R Edsall1, Dimitrios Rigopoulos2, Melissa M Markofski3, Andreas D Flouris2, Petros C Dinas2.
Abstract
BACKGROUND: Brown adipose tissue (BAT) provides a minor contribution to diet-induced thermogenesis (DIT)-the metabolic response to food consumption. Increased BAT activity is generally considered beneficial for mammalian metabolism and has been associated with favorable health outcomes. The aim of the current systematic review was to explore whether nutritional factors and/or diet affect human BAT activity.Entities:
Keywords: BAT; diet-induced thermogenesis; thermic effect of food
Year: 2020 PMID: 32927664 PMCID: PMC7551565 DOI: 10.3390/nu12092752
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Summary of risk of bias assessment for randomized controlled trials.
Figure 2Summary of risk of bias assessment for observational trials.
Figure 3The acute effects of a single meal on human brown adipose tissue activity. SD: Standard deviation, 95%. CI: Confidence interval.
Figure 4The chronic effects of diet on human brown adipose tissue activity. SD: Standard deviation, 95%. CI: Confidence interval.
Figure 5The chronic effects of diet and supplements on resting energy expenditure. SD: Standard deviation, 95%. CI: Confidence interval.
Figure 6The acute effects of diet and supplements on resting energy expenditure. SD: Standard deviation, 95%. CI: Confidence interval.
Figure 7The acute effects of diet and supplements on resting energy expenditure, with regard to ambient temperature. SD: Standard deviation, 95%. CI: Confidence interval.
Risk of bias assessment for randomized controlled trials.
| First Author | Random Sequence Generation | Allocation Concealment | Blinding of Participants and Researchers | Blinding of Outcome Assessment | Incomplete Outcome Data | Selective Reporting | Other Bias |
|---|---|---|---|---|---|---|---|
| Selection | Performance | Detection | Attrition | Reporting | Other | ||
| Ahmadi, 2013 |
|
|
|
|
|
|
|
| Boon, 2019 |
|
|
|
|
|
|
|
| Nagai, 2005 |
|
|
|
|
|
|
|
| Schlogl, 2013 |
|
|
|
|
|
|
|
| Vrieze, 2012 |
|
|
|
|
|
|
|
| Wijers, 2007 |
|
|
|
|
|
|
|
| Yoshioka, 1998 |
|
|
|
|
|
|
|
| Yoneshiro, 2013 |
|
|
|
|
|
|
|
| Yoneshiro, 2017 |
|
|
|
|
|
|
|
Key: +: low risk of bias; -: high risk of bias; ?: unclear risk of bias.
Risk of bias assessment for observational trials.
| First Author | Selection | Performance | Detection | Attrition | Reporting | Confounding |
|---|---|---|---|---|---|---|
| Barquissau, 2018 |
|
|
|
|
|
|
| Dinas, 2017 |
|
|
|
|
|
|
| Hibi, 2016 |
|
|
|
|
|
|
| Matsumoto, 2001 |
|
|
|
|
|
|
| Matsumoto, 2000 |
|
|
|
|
|
|
| Nagai, 2011 |
|
|
|
|
|
|
| Peterson, 2017 |
|
|
|
|
|
|
| Peterson, 2016 |
|
|
|
|
|
|
| Robinson, 2019 |
|
|
|
|
|
|
| Schutz, 1984 |
|
|
|
|
|
|
| Sun, 2018 |
|
|
|
|
|
|
| Vosselman, 2013 |
|
|
|
|
|
|
| Weststrate, 1993 |
|
|
|
|
|
|
| Williams, 2008 |
|
|
|
|
|
|
| Yoneshiro, 2012 |
|
|
|
|
|
|
Key: +: low risk of bias; -: high risk of bias; ?: unclear risk of bias; N: not applicable.
Characteristics of the included studies.
| Study | Design | Participants Characteristics | Intervention | Main Outcome |
|---|---|---|---|---|
|
| RCT | 65 (n = 33 AGE-S (aged garlic extract plus supplement); n = 32 placebo) participants 40–79 yr. and free from clinical coronary artery disease; 51 M and 14 F. | Daily capsule of placebo or AGE-S (aged garlic-extract (250 mg), vitamin-B12 (100 µg), folic-acid (300 µg), vitamin-B6 (12.5 mg) and L-arginine (100 mg)) for 12-months. | AGE-S participants showed higher brown epicardial adipose tissue (bEAT) (AGE-S: 43.4 ± 15.9; placebo: 33.7 ± 13.89) and temperature-rebound when compared to placebo ( |
|
| SGDS | 289 obese males (n = 101, BMI: 33.7 ± 4.6 kg/m2, age: 43.4 ± 5.9 yr.) and females (n = 188, BMI: 34.5 ± 4.6 kg/m2, age: 41.7 ± 6.4 yr.). | Dietary intervention performed in two phases. Phase one: 8-week very low-calorie diet. Phase two: 6-month weight maintenance period. | Decreased browning of subcutaneous abdominal white adipose tissue was reported after the very low-calorie diet. Changes observed in body fat and insulin resistance were not dependent on changes in brown and beige fat markers. |
|
| RCT | 10 prediabetic overweight Dutch South Asian males, (age: 46.5 ± 2.8 yr., BMI: 30.1 ± 1.1 kg/m2) and 10 prediabetic Dutch males of European decent (age 47.5 ± 2.0 yr., BMI: 30.7 ± 1.2 kg/m2). | Participants ingested either L-arginine (9 g/day) or placebo tablets for 6 weeks followed by a 4-week washout period. | Six weeks of L-arginine supplementation did not influence body weight, BMI, fat mass or lean mass in either the Dutch South Asian group or the Dutch males of European decent. The mean and maximum BAT activity values (expressed as SUV) did not differ between groups and were not influenced by L-arginine treatment. |
|
| CSS | 32 healthy, non-smoking males (age: 36.1 ± 7.4 yr., BMI: 27.1 ± 4.6 kg/m2) free from chronic disease. | Diet recalls were retrieved from two weekdays and one weekend day (randomly selected) to assess energy/nutrient intake during the week prior to measurements. Measurements included body composition, REE and a subcutaneous fat biopsy following a 12-h fast and after refraining from exercise, alcohol and passive smoking for 72 h. Fat biopsy samples were used to assess UCP1, PGC-1α, PPARα and PPARγ mRNA expression. | Diet was not associated with browning formation markers of subcutaneous adipose tissue in healthy men. UCP1 mRNA in white adipose tissue was not linked to body weight or body composition. Activation of the PGC-1α, PPARα and PPARγ genes could collectively indicate browning formation of white adipose tissue through increased UCP1 expression. |
|
| CSS | 21 healthy males between 20–50 yr. with a BMI of 18.0–24.9 kg/m2. Subjects were divided into BAT-positive (n = 13) and BAT-negative (n = 8) groups according to F-FDG-PET/CT findings. | A prescribed meal was given at 18:00 h before energy metabolism was measured. Subjects ate the same meal/quantity at 09:00 h (breakfast), 14:00 h (lunch) and 19:00 (dinner) and were instructed to drink water ad libitum. The three meals were comprised. BAT activity was measured using PET/CT. | Diet induced thermogenesis and fat utilization were higher in BAT-positive subjects than in the BAT-negative subjects. These findings suggest that brown adipose tissue may have a physiologic role in energy metabolism. Mean SUV max was 8.5 ± 4.8 in the BAT-positive group and 1.1 ± 0.4 in the BAT-negative group ( |
|
| CT | 8 lean (age: 19.6 ± 0.3 yr., BMI: 21.0 ± 0.6 kg/m2) and 8 obese (age: 20.1 ± 0.4 yr., BMI: 28.8 ± 1.0 kg/m2) females. | Participants were served rice with spicy yellow curry sauce containing 3 mg of capsaicin over a ten-minute period. The experimental meal was composed of 60% carbohydrate, 30% fat and 10% protein. The energy content of the meal was 2016 kJ. DIT was assessed via energy expenditure measurements. | The lean females experienced an increase in energy expenditure after the meal (5574.7 ± 221.2 to 6114.7 ± 239 kj*day-1; |
|
| CT | 8 obese (age: 20.0 ± 0.3 yr., BMI: 29.0 ± 1.0 kg/m2) and 8 non-obese (age: 19.8 ± 0.9 yr., BMI: 18.6 ± 0.4 kg/m2) females. | Participants consumed a mixed food meal (480 kcal; 55% carbohydrate, 15% protein and 30% fat) over a 5-min period. DIT was assessed via energy expenditure measurements. | Energy expenditure was increased in the non-obese group (0.79 ± 0.02 to 0.90 ± 0.02 kcal/min, |
|
| RCT | 13 healthy, lean (age: 8.8 ± 0.4 yr., BMI: 16.5 ± 0.4 kg/m2) and 10 obese (age: 9.2 ± 0.4 yr., BMI: 23.3 ± 0.8 kg/m2) boys. | Different menus served on two different days were provided to the two groups. One menu consisted of a high carbohydrate meal (70% carbohydrate, 20% fat and 10% protein) and the other consisted of a high fat meal (20% carbohydrate, 70% fat and 10% protein). Each meal was standardized, 80 kJ per kg of actual body mass (30.9 ± 1.0 kg) in lean boys and 80 kJ per kg of ideal body mass (33.2 ± 1.6 kg) in obese boys. Thermic effect of food (TEF) was assessed via energy expenditure measurements. | The obese group experienced a smaller increase in VO2 (lean, 1.25 ± 0.02 L; obese, 1.15 ± 0.20 L; |
|
| SGDS | 17 female volunteers (age: 20–22 yr.) with normal weight and BMI, percent body fat between 25.1–38.5%, free from disease and were not using any treatment known to affect weight loss. | Participants were fed a hypoenergetic diet consisting of a 30% reduction in energy intake during a 2-week energy-restriction period. During the energy-restriction period, participants were restricted to 5.0 MJ (1200 kcal)/d (62% carbohydrate, 19% protein and 19% fat), consisting of 3 isoenergetic, nutritionally balanced meals. During the experimental period, participants were not permitted to consume soft drinks, alcoholic beverages or any food not included in the test meals. | Following the intervention, the G allele participants experienced significantly smaller changes in body weight, BMI and waist circumference compared to the A/A genotype participants. These data suggest that the UCP1 gene −3826 G allele could contribute to smaller weight loss after a short-term, controlled-energy diet in young, lean women. |
|
| SGDS | 9 healthy, non-smoking males (age: 23 ± 3 yr., 23.0 ± 1.8 kg/m2). Volunteers consumed less than 3 alcoholic drinks/day, were not currently on medication, had no recent change in body weight (>2 kg in the prior 6 months), had no impaired fasting glucose (>100 mg/dL), did not exercise intensely (>3 times/week) and had no chronic disease. | Participants were exposed to cold for 20 min per day, for five days per week for four weeks. DIT was determined during a 24-h thermic response to one day of 50% overfeeding. | Participants were overfed by 50.2 ± 4.6% at baseline versus 53.1 ± 3.4% post-cold acclimation. 24-h thermic response following overfeeding was similar at baseline (2166 ± 206 kcal/day) and following the four-week cold intervention (2118 ± 188 kcal/day; |
|
| SGDS | 14 males (age: 24 ± 3 yr., BMI: 24.5 ± 1.6 kg/m2). | Participants were overfed by 40% for 8 weeks. The diet composed of 41% carbohydrate, 44% fat and 15% protein. The PBRC Metabolic Kitchen prepared all 21 meals during the 8-week intervention. BAT activity was measured using infrared imaging of the supraclavicular BAT depot. | Metabolic adaptation increased from -0.9 ± 3.9% to 4.7 ± 5.6% ( |
|
| CSS | 36 children (16 boys and 20 girls; age: 8.5–11.8 yr.). | A survey on the child’s diet was completed by the parents. Based on the answers, foods were sorted into categories of carbohydrate, dairy, fruit, protein, savory, sweet and vegetable. Infrared thermography of the neck and upper thorax was utilized to examine BAT activity. | BAT thermogenesis may be altered by dietary intake in a sex-specific manner. A correlation between the supraclavicular region temperature and report of vegetable and protein consumption was observed in young girls. After adjustment for multiple testing in the study sample, the relationships were no longer statistically significant. There were no associations between supraclavicular region temperature and food consumption in any category for the young boys. There was no difference in vegetable and protein consumption scores between girls and boys. |
|
| RCT | 16 healthy women (n = 7, age: 30.7 ± 8.6 yr., BMI 28.0 ± 6.5 kg/m2) and men (n = 9, age: 31.1 ± 11.3 yr., BMI: 25.1 ± 4.6 kg/m2). | Volunteers followed a weight-maintenance diet composed of 50% carbohydrate, 30% fat and 20% protein. Each participant completed 24-h EE measures, during energy balance, fasting and during 200% over feeding (60% fat, 20% protein, 20% carbohydrate). The first six participants had a second PET/CT after 36 h of fasting to further examine BAT activation at 22 °C. Other participants had a second PET/CT after 24 h of overfeeding at 22 °C but only if they showed cold-induced BAT activity. | Cold-induced BAT activity was seen in 8 of 10 participants after overfeeding. DIT was 280 ± 164 kcal during overfeeding vs 140 ± 116 kcal during energy balance ( |
|
| SGDS | 28 females (age: 19–44 yr.) 20 were obese (percent body fat: 38.6 ± 0.7%), and 8 were non-obese (percent body fat: 24.7 ± 0.9%). | For the weight maintenance period, 1–2 weeks before the study, subjects consumed their normal diet. Each subject ate three meals prepared by a dietician including normal “natural” foods (breakfast: bread, butter, marmalade, milk; lunch and dinner: bread, meat or fish, vegetables, dessert). Decaffeinated coffee was served at each meal, and no alcohol was consumed during the experiment. Energy expenditure was measured for 24 h in a respiration chamber. | The thermogenic response to the three meals was found to be low in the obese participants (8.7 ± 0.8%) when compared to the controls’ (14.8 ± 1.1%). The thermogenic response induced by the three meals was negatively correlated with body weight (r = −0.552, |
|
| CT | 20 healthy males and females (age: 21–35 yr., BMI: 18.5–26.0 kg/m2). All participants were healthy, no history of diabetes or cardiovascular disease, smoke or use tobacco. They did not adhere to special diets or take medication known to alter brown adipose tissue metabolism. | PET/CT measurement and whole-body calorimetry were assessed after capsinoid ingestion (12 mg) or cold exposure (~14 °C) in a crossover design. | Capsinoid ingestion did not result in detectable BAT activation, as all participants in each trial stayed at or below the level of baseline-detectable activity assessed during the PET/CT scan. The results showed that ingestion of capsinoids led to a bigger increase in energy expenditure (10%) in BAT-positive participants than in BAT-negative participants (5%). |
|
| SGDS | 11 lean males (age: 23.6 ± 2.1 yr., BMI: 22.4 ± 2.1 kg/m2). | Participants consumed a high calorie and carbohydrate rich meal (1622 ± 222 kcal; 78% carbohydrate, 12% protein, 10% fat). BAT activity was assessed by (18F) FDG-PET/CT following consumption of the meal. BAT assessed during 2 h of cold exposure served as a positive control. Energy expenditure was assessed via indirect calorimetry. | BAT activity following the meal was lower compared to cold-induced BAT activity. There was no direct relationship between BAT activity and DIT. |
|
| RCT | 10 healthy, lean males (age: 18–32 yr., BMI 20–24 kg/m2). | Each volunteer underwent two PET/CT scans two weeks apart. The first scan was completed after an overnight fast and the second scan was completed after an overnight fast with a standardized meal consumed 90 min beforehand. The meal was a chicken-bacon sandwich and 200 mL of whole milk (545 kcal), containing 34g of fat, 37g or carbohydrates and 23g of protein. | BAT activity was observed in 6 of 10 volunteers. All subjects with BAT activity had higher SUVmax in the fasted state (median, 13.1 g/mL; range, 6.1–27.6 g/mL) than in the post-meal state (median, 6.8 g/mL; range 2.1–13.4 g/mL) ( |
|
| SGDS | 49 non-obese males and 54 women (22 non-obese and 32 obese). | DIT was assessed using a ventilated-hood system. In males: Study 1 tested the thermic effect of alcohol. Study 2 examined the impact of palatability on DIT. Study 3 examined a 2-week dietary intervention on individual energy metabolism. In females: Studies 1 and 2, were similar to the studies conducted in males. Studies 3 and 4 examined the effect of the ovular phase of the menstrual cycle on RMR and DIT. Study 5 looked at the effect of body-fat distribution in obesity on energy metabolism. Study 6 studied the effect of body-fat distribution on weight loss and energy metabolism in obese women. DIET: nine subjects, four males and five females, followed a 2-week diet. Food was provided in a 4-day rotating menu with minor differences in energy content (CV<5%) and nutrient composition (CV protein, fat < 10%, CV carbohydrates < 15%) between the four menus. Mean energy intake was 9.3 ± 0.5 MJ/d. | Variation in DIT was not changed when the diet was controlled. Total DIT values were significantly higher ( |
|
| RCT | 13 lean males (age 22.8 ± 1.7 yr., BMI: 22.96 ± 0.90 kg/m2). | Participants underwent three different experimental conditions in a respiration chamber once for 36 h (control meal) and twice for 84 h (overfeeding at 16 °C and at 22 °C). | Overfeeding showed significant increases in EE (0.77 MJ/d, |
|
| CSS | Fasting protocol (n = 1229; age: 58 ± 16 yr., male 58%, female 48%). High fat, low carbohydrate, protein permitted diet (n = 741; age: 58 ± 16 yr., male 53%, female 47%). | Consumption of a high fat, very low carbohydrate, protein permitted diet. Brown adipose tissue activity was assessed via PET/CT measurements. | The results showed a difference between the fasting and high fat, low carbohydrate group in blood glucose and frequency of FDG uptake by hypermetabolic brown adipose tissue. Participants who consumed the high-fat diet experienced a significant reduction in the frequency of hypermetabolic BAT uptake ( |
|
| SGDS | 18 healthy males (age: 20–32 yr.) separated into BAT-positive (n = 10) and BAT-negative (n = 8) groups after FDG uptake was assessed. | 2 h of cold exposure while wearing light clothing after oral ingestion of capsinoids (9 mg). Brown adipose tissue was assessed using PET/CT measurements. | Energy expenditure increased by 15.2 ± 2.6 kJ/h in 1 h in the BAT-positive group and by 1.7 ± 3.8 kJ/h in the BAT-negative group following the intervention ( |
|
| RCT | 51 healthy males (age: 22.4 ± 0.5 yr., BMI: 22.0 ± 0.4 kg/m2). Only 10 males were selected to complete the capsinoid test, with low or undetectable BAT activity. | The 10 males ingested capsules containing 9 or 0 mg (placebo) capsinoids every day for 6 weeks. BAT was assessed via PET/CT measurements. | Daily ingestion of capsinoids (9 mg) and cold exposure can brown adipose tissue even among individuals who have lost active brown adipose tissue. |
|
| RCT | 15 healthy males participated in the acute catechin trial. 10 healthy males who showed low or no BAT activity participated in the chronic catechin trial. | The experiment consisted of a single ingestion of a beverage containing 615 mg catechin and 77 mg of caffeine in 350 mL. The control beverage contained 0 mg of catechin and 81 mg of caffeine. Ingestion occurred for 5 weeks, twice per day. Participants maintained their daily lifestyle, including dietary intake and physical activity during the experimental period. BAT activity was assessed via PET/CT measurements. | Ingestion of the catechin beverage increased energy expenditure in 9 participants who had active BAT (mean ± SEM: +15.24 ± 1.48 kcal, |
|
| RCT | 13 healthy females (age: 25.8 ± 2.8 yr., body weight: 54.2 ± 6.4 kg). | Women consumed a standardized meal before beginning the experiment with a standardized breakfast. The breakfast fell under one of the following four conditions: high fat meal, high fat and red-pepper (10 g) meal, high calorie meal or high calorie and red-pepper meal. The experimental meals consisted of a stir fry of rice, scallops, shrimps, bacon, green peppers, green peas, onions and tomatoes. DIT was assessed via energy expenditure measurements. | Diet induced thermogenesis was significantly higher after the high calorie meals than after the high fat meal. The addition of red pepper to the meals significantly increased diet-induced thermogenesis and lipid oxidation, especially in the high fat meal. |
Key: RCT = Randomized controlled trial; AGE-S = Aged garlic extract with supplement; SGDS = Single group design study; FDG-PET/CT = Fluorodeoxyglucose-positron emission tomography/computed tomography; BMI = Body mass index; BAT = Brown adipose tissue; CSS = Cross-sectional study; DIT = Diet-induced thermogenesis; SUV = Standardized uptake value; UCP1 = Uncoupling protein one; CT = Controlled trial; EE = Energy expenditure; SEM = Standard error of the mean.
The study’s Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist.
| Section/Topic | Identification Number | Checklist Item | Reported on Page |
|---|---|---|---|
|
| |||
| Title | 1 | Identify the report as a systematic review, meta-analysis or both. | 1 |
|
| |||
| Structured summary | 2 | Provide a structured summary including, as applicable, background; objectives; data sources; study eligibility criteria, participants and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. | 1 |
|
| |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. | 1–2 |
| Objectives | 4 | Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes and study design (PICOS). | 2 |
|
| |||
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address) and, if available, provide registration information including registration number. | 2 |
| Eligibility criteria | 6 | Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. | 2–3 |
| Information sources | 7 | Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. | 2 |
| Search | 8 | Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. | 2 |
| Study selection | 9 | State the process for selecting studies (i.e., screening, eligibility, included in systematic review and, if applicable, included in the meta-analysis). | 2–3 |
| Data collection process | 10 | Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. | 3 |
| Data items | 11 | List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. | 3 |
| Risk of bias in individual studies | 12 | Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level) and how this information is to be used in any data synthesis. | 3 |
| Summary measures | 13 | State the principal summary measures (e.g., risk ratio, difference in means). | 3 |
| Synthesis of results | 14 | Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis. | 3 |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies). | 3 |
| Additional analyses | 16 | Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. | N/A |
|
| |||
| Study selection | 17 | Give numbers of studies screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. | 3–4 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. | 3–4 |
| Risk of bias within studies | 19 | Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). | 4 and Appendix |
| Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study, (a) simple summary data for each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot. | 4–6 |
| Synthesis of results | 21 | Present the main results of the review. If meta-analyses are done, include for each confidence intervals and measures of consistency | 3–6 |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15). | 4 and Appendix |
| Additional analysis | 23 | Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression (see Item 16)). | N/A |
|
| |||
| Summary of evidence | 24 | Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users and policy makers). | 6–7 |
| Limitations | 25 | Discuss limitations at study and outcome level (e.g., risk of bias) and at review-level (e.g., incomplete retrieval of identified research, reporting bias). | 8 |
| Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence and implications for future research. | 7–8 |
|
| |||
| Funding | 27 | Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. | N/A |